Circulating pattern and genomic characteristics of influenza B viruses in Taiwan from 2003 to 2014

Journal of the Formosan Medical Association

Volumn 115, Issue 7, 2016, Pages 510-522

  Kuo, Shu Ming ^a   Chen, Guang Wu ^a,b   Velu, Arul Balaji ^a   Dash, Srinivas ^a   Han, Yi Ju ^a   Tsao, Kuo Chien ^c   Shih, Shin Ru ^a,c,d  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d Research Center for Emerging Viral Infections   (Taiwan)

Author keywords

Evolution; Glycosylation site; Hemagglutinin; Influenza B virus; Neuraminidase reassortment

Indexed keywords

AMINO ACID; EPITOPE; HEMAGGLUTININ; SIALIDASE; HEMAGGLUTININ HA1, INFLUENZA B VIRUS; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS RNA;

AMINO ACID SEQUENCE; ARTICLE; CLADISTICS; CORRELATION ANALYSIS; EPIDEMIC; EVOLUTION; GENE MUTATION; GENETIC REASSORTMENT; GLYCOSYLATION; INFLUENZA B VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; SEASON; TAIWAN; VIRAL GENETICS; VIRUS GENOME; VIRUS STRAIN; GENETICS; GENOMICS; HUMAN; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MUTATION; PHYLOGENY; SEQUENCE ANALYSIS; VIROLOGY;

GENOMICS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MUTATION; NEURAMINIDASE; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, RNA; TAIWAN;

EID: 84962071181     PISSN: 09296646     EISSN: 18760821     Source Type: Journal    
DOI: 10.1016/j.jfma.2016.01.017     Document Type: Article

References (43)

1. Chen G.W., Gong Y.N., Shih S.R. Influenza A virus plasticity-A temporal analysis of species-associated genomic signatures. J Formos Med Assoc 2015, 114:456-463.
2. Nerome R., Hiromoto Y., Sugita S., Tanabe N., Ishida M., Matsumoto M., et al. Evolutionary characteristics of influenza B virus since its first isolation in 1940: dynamic circulation of deletion and insertion mechanism. Arch Virol 1998, 143:1569-1583.
3. McCullers J.A., Wang G.C., He S., Webster R.G. Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature. J Virol 1999, 73:7343-7348.
4. Xu X., Lindstrom S.E., Shaw M.W., Smith C.B., Hall H.E., Mungall B.A., et al. Reassortment and evolution of current human influenza A and B viruses. Virus Res 2004, 103:55-60.
5. Earp L.J., Delos S.E., Park H.E., White J.M. The many mechanisms of viral membrane fusion proteins. Curr Top Microbiol Immunol 2005, 285:25-66.
6. Palese P., Compans R.W. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J Gen Virol 1976, 33:159-163.
7. Quan F.S., Kim M.C., Lee B.J., Song J.M., Compans R.W., Kang S.M. Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection. Virology 2012, 430:127-135.
8. Chen R., Holmes E.C. The evolutionary dynamics of human influenza B virus. J Mol Evol 2008, 66:655-663.
9. McCullers J.A., Saito T., Iverson A.R. Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol 2004, 78:12817-12828.
10. Chi X.S., Bolar T.V., Zhao P., Rappaport R., Cheng S.M. Cocirculation and evolution of two lineages of influenza B viruses in Europe and Israel in the 2001-2002 season. J Clin Microbiol 2003, 41:5770-5773.
11. Matsuzaki Y., Sugawara K., Takashita E., Muraki Y., Hongo S., Katsushima N., et al. Genetic diversity of influenza B virus: the frequent reassortment and cocirculation of the genetically distinct reassortant viruses in a community. J Med Virol 2004, 74:132-140.
12. Kaji M., Watanabe A., Aizawa H. Differences in clinical features between influenza A H1N1, A H3N2, and B in adult patients. Respirology 2003, 8:231-233.
13. Sakudo A., Baba K., Ikuta K. Analysis of Vis-NIR spectra changes to measure the inflammatory response in the nasal mucosal region of influenza A and B virus-infected patients. J Clin Virol 2012, 55:334-338.
14. Ran Z., Shen H., Lang Y., Kolb E.A., Turan N., Zhu L., et al. Domestic pigs are susceptible to infection with influenza B viruses. J Virol 2015, 89:4818-4826.
15. Chen G.W., Shih S.R., Hsiao M.R., Chang S.C., Lin S.H., Sun C.F., et al. Multiple genotypes of influenza B viruses cocirculated in Taiwan in 2004 and 2005. J Clin Microbiol 2007, 45:1515-1522.
16. Jian J.W., Lai C.T., Kuo C.Y., Kuo S.H.S., Hsu L.C., Chen P.J., et al. Genetic analysis and evaluation of the reassortment of influenza B viruses isolated in Taiwan during the 2004-2005 and 2006-2007 epidemics. Virus Res 2008, 131:243-249.
17. Yang J.R., Huang Y.P., Chang F.Y., Hsu L.C., Lin Y.C., Huang H.Y., et al. Phylogenetic and evolutionary history of influenza B viruses, which caused a large epidemic in 2011-2012, Taiwan. PLoS One 2012, 7:e47179.
18. Lu Y., Welsh J.P., Swartz J.R. Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines. Proc Natl Acad Sci U S A 2014, 111:125-130.
19. Tippmann H.F. Analysis for free: comparing programs for sequence analysis. Brief Bioinform 2004, 5:82-87.
20. Drummond A.J., Rambaut A.B.E.A.S.T. Bayesian Evolutionary Analysis by Sampling Trees. BMC Evol Biol 2007, 7:214.
21. Drummond A.J., Suchard M.A., Xie D., Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol 2012, 29:1969-1973.
22. Bouckaert R., Heled J., Kuhnert D., Vaughan T., Wu C.H., Xie D., et al. BEAST 2: a software platform for Bayesian evolutionary analysis. PLoS Comput Biol 2014, 10:e1003537.
23. Pond S.L., Frost S.D. Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics 2005, 21:2531-2533.
24. Delport W., Poon A.F., Frost S.D., Kosakovsky Pond S.L. Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology. Bioinformatics 2010, 26:2455-2457.
25. Wei C.J., Boyington J.C., Dai K., Houser K.V., Pearce M.B., Kong W.P., et al. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci Transl Med 2010, 2. 24ra1.
26. Knossow M., Skehel J.J. Variation and infectivity neutralization in influenza. Immunology 2006, 119:1-7.
27. Whittle J.R., Zhang R., Khurana S., King L.R., Manischewitz J., Golding H., et al. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc Natl Acad Sci U S A 2011, 108:14216-14221.
28. Nakagawa N., Kubota R., Nakagawa T., Okuno Y. Neutralizing epitopes specific for influenza B virus Yamagata group strains are in the 'loop'. J Gen Virol 2003, 84:769-773.
29. Jumat M.R., Sugrue R.J., Tan B.H. Genetic characterisation of influenza B viruses detected in Singapore, 2004 to 2009. BMC Res Notes 2014, 7:863.
30. Vijaykrishna D., Holmes E.C., Joseph U., Fourment M., Su Y.C., Halpin R., et al. The contrasting phylodynamics of human influenza B viruses. eLife 2015, 4:e05055.
31. Fujisaki S., Takashita E., Yokoyama M., Taniwaki T., Xu H., Kishida N., et al. A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs. Biochem Biophys Res Commun 2012, 429:51-56.
32. Bastien N., Gubbay J.B., Richardson D., Sleeman K., Gubareva L., Li Y. Detection of an influenza B virus strain with reduced susceptibility to neuraminidase inhibitor drugs. J Clin Microbiol 2011, 49:4020-4021.
33. Cheam A.L., Barr I.G., Hampson A.W., Mosse J., Hurt A.C. In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors. Antiviral Res 2004, 63:177-181.
34. Gubareva L.V., Webster R.G., Hayden F.G. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants. Antimicrob Agents Chemother 2001, 45:3403-3408.
35. Hurt A.C., Iannello P., Jachno K., Komadina N., Hampson A.W., Barr I.G., et al. Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient. Antimicrob Agents Chemother 2006, 50:1872-1874.
36. Hatakeyama S., Ozawa M., Kawaoka Y. In vitro selection of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. Clin Microbiol Infect 2011, 17:1332-1335.
37. Doyle T.M., Li C., Bucher D.J., Hashem A.M., Van Domselaar G., Wang J., et al. A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains. Biochem Biophys Res Commun 2013, 441:226-229.
38. Garg S., Moore Z., Lee N., McKenna J., Bishop A., Fleischauer A., et al. A cluster of patients infected with I221V influenza b virus variants with reduced oseltamivir susceptibility-North Carolina and South Carolina, 2010-2011. J Infect Dis 2013, 207:966-973.
39. Hurt A.C., Holien J.K., Parker M.W., Barr I.G. Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses. Drugs 2009, 69:2523-2531.
40. Carr S., Ilyushina N.A., Franks J., Adderson E.E., Caniza M., Govorkova E.A., et al. Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer. J Pediatric Infect Dis Soc 2011, 30:284-288.
41. Baum E.Z., Wagaman P.C., Ly L., Turchi I., Le J., Bucher D., et al. A point mutation in influenza B neuraminidase confers resistance to peramivir and loss of slow binding. Antiviral Res 2003, 59:13-22.
42. Hu Y.J., Chow K.C., Liu C.C., Lin L.J., Wang S.C., Wang S.D., et al. Using combinatorial bioinformatics methods to analyze annual perspective changes of influenza viruses and to accelerate development of effective vaccines. J Formos Med Assoc 2015, 114:774-778.
43. Tsai H.P., Wang H.C., Kiang D., Huang S.W., Kuo P.H., Liu C.C., et al. Increasing appearance of reassortant influenza B virus in Taiwan from 2002 to 2005. J Clin Microbiol 2006, 44:2705-2713.